Blog RSS




Johnson & Johnson recalls five sunscreens over traces of carcinogen

Johnson & Johnson recalls five sunscreens over traces of carcinogen Maya Yang Fri 16 Jul 2021 03.22 AEST Guardian News Full article here Johnson & Johnson is recalling five of its sunscreen products in the US after low levels of benzene, a carcinogen, was found in its products. The recall comes after Valisure, an independent laboratory, raised the alarm over benzene’s presence in Johnson & Johnson’s products. In a report released in May, Valisure noted that “27% of samples … contained detectable benzene and some batches contained up to three times the conditionally restricted FDA concentration limit of 2 parts per million”.  The affected products, all packaged in aerosol cans, include four Neutrogena sprays – Beach Defense, CoolDry Sport, Invisible Daily Defense and...

Continue reading



SOME MORE ABOUT US

As well as running High Noon I work full time as a Lifeguard at Sunshine Beach in Queensland, Australia. Working all day on the beach and surfing during lunch breaks means I regularly spending all day in the sun. This is why I created a zinc that stays on for hours in and out of the water. We started developing our product in 2011 and were lucky enough to be able to test our product on a large number of Lifeguards and Surf Instructors who spend all day in the elements. 10 years later we are proud to have loyal following of Surfers, Lifeguards, Paddlers, Fisherman and many other core outdoor people.

Continue reading




Sunscreen Chemicals Accumulate in Body at High Levels (Wall St Journal article)

Sunscreen Chemicals Accumulate in Body at High LevelsFDA study looked at six common ingredients; proposed rule to test safety remains on holdPrevious research indicates a possible link between some of the chemicals in sunscreens and health risks.By Jo Craven McGintyJuly 17, 2020 5:30 am ETFor the second time in less than a year, a study of common sunscreen ingredients has established that the chemicals are absorbed into the bloodstream at concentrations far greater than the Food and Drug Administration’s safety threshold.According to the FDA, if active ingredients are found in the blood at a level of 0.5 nanograms per milliliter or higher, they should be analysed to determine whether they increase the risk of cancer, birth defects or other adverse effects.The...

Continue reading